Single-source·Aug 24, 2026·1 sources analyzed
FDA approves new blood test for Alzheimer's disease
The FDA has approved a new blood test for Alzheimer’s disease, expanding diagnostic options for the condition. This approval represents the fourth such test authorized in a short period. (sources: thehill)
Image: thehill
Modern Action Briefing
The FDA has approved Roche's Elecsys Phospho-Tau blood test for Alzheimer’s disease. This marks the fourth approval of a blood test for the disease in less than two years.
- The FDA has granted approval for Roche's Elecsys Phospho-Tau blood test.
- This is the fourth blood test for Alzheimer’s disease approved by the FDA in under two years.
- The approval aims to enhance diagnostic capabilities for Alzheimer’s disease.
Why it matters
The approval of new diagnostic tests may improve early detection and management of Alzheimer’s disease.
Sources used · 1 source